ReviewMolecular medicine (Cambridge, Mass.)2021

ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer.

Dantong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.